TrialCell reports. Medicine2026

Spatial architecture contributes to failure of bulk biomarker-guided neoadjuvant immunotherapy selection in bladder cancer: The DUTRENEO study.

Enrique Grande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.